Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis.
Nigel Mackman(University of North Carolina at Chapel Hill), Megan Jay(University of Cincinnati Medical Center), Shannon M. Shearer, Caris Wadding-Lee(University of Cincinnati), Benjamin E. Tourdot(Cincinnati Children's Hospital Medical Center), Tyler W. Benson(Augusta University), Alan Daugherty, Joel Thompson, Anthony Spuzzillo(University of Cincinnati), A Phillip Owens III, Deborah A. Howatt(University of Kentucky)
Cited by 0
Related Papers
Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
|Blood|2014|132
ENTPD-1 disrupts inflammasome IL-1β–driven venous thrombosis
|Journal of Clinical Investigation|2019|116
First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis
|Arteriosclerosis Thrombosis and Vascular Biology|2017|112
The emerging role of oxylipins in thrombosis and diabetes
|Frontiers in Pharmacology|2014|101